ISDA: 6GGN

Deposition Date 2018-05-03

Release Date 2018-09-26

Last Version Date 2024-01-17

Entry Detail

PDB ID:

6GGN

Keywords:

CELL CYCLE

Title:

In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitor

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli BL21

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.00 Å

R-Value Free:

0.23

R-Value Work:

0.22

R-Value Observed:

0.22

Space Group:

P 61 2 2

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:E3 ubiquitin-protein ligase Mdm2
Gene (Uniprot):MDM2
Chain IDs:A
Chain Length:96
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:Q00987 Pfam ID:PF02201 EC:2.3.2.27

Ligand Molecules

EYH

Primary Citation

In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitor.

Vaupel, A, Holzer, P, Ferretti, S, Guagnano, V, Kallen, J, Mah, R, Masuya, K, Ruetz, S, Rynn, C, Schlapbach, A, Stachyra, T, Stutz, S, Todorov, M, Jeay, S, Furet, P.Show

Bioorg. Med. Chem. Lett. 28 3404 3408 (2018)

PMID: 30217415 DOI: 10.1016/j.bmcl.2018.08.027

Abstact

Small molecule inhibitors of the p53-MDM2 protein complex are under intense investigation in clinical trials as anti-cancer agents, including our first generation inhibitor NVP-CGM097. We recently described the rational design of a novel pyrazolopyrrolidinone core as a new lead structure and now we report on the synthesis and optimization of this to provide a highly potent lead compound. This new compound displayed excellent oral efficacy in our preclinical mechanistic in vivo model and marked a significant milestone towards the identification of our second generation clinical candidate NVP-HDM201.

Legend

Protein

Chemical

Disease

Primary Citation of related structures

Abstact

Feedback Form